The LUMIBIRD Group, the European leader in laser technologies, announces the launch by Lumibird Medical of C.DIAG®, a new-generation dry eye diagnostic aid platform incorporating Artificial Intelligence. This Europe-wide launch follows the CE marking certified by LNE-GMED on 30 April 2024. This new product completes the C.SUITETM offering with diagnosis,...
HiPaaS Inc, a leading healthcare technology firm, is excited to unveil its 'Make AI Real' capabilities. This initiative aims to help healthcare companies implement Artificial Intelligence (AI) solutions to enhance patient care, simplify administration, and reduce costs.
HiPaaS 'Make AI Real' empowers hospitals, healthcare insurers, pharmacies, radiology centers, and life...
Ultra-high-field technology, ultra-high-gradient technology, and advances in artificial intelligence take center stage.
United Imaging, a global leader in manufacturing advanced medical imaging and radiotherapy equipment, will unveil its latest MRI technology, boasting incredible advancements across various fronts, as a Gold sponsor at this year's ISMRM meeting.
The company's exhibit at this year's...
Andor Health, an AI-first company reimagining virtual care, announces a groundbreaking initiative aimed at transforming the patient experience in MUSC Health emergency departments. The program uses artificial intelligence (AI)-powered ThinkAndor® to reduce wait times and enhance the quality of care for patients.
The demand for emergency care continues to rise, leading...
Deepcell, a pioneer in artificial intelligence (AI)-powered single cell analysis to fuel deep biological discoveries, announced the first commercial placement of the REM-I platform at Erasmus Medical Center in Rotterdam. This commercial milestone follows placements of pre-commercial instruments at laboratories in Europe and the U.S. for Beta testing. In addition,...
WELL Health Technologies Corp., a digital health company focused on tech-enabling healthcare providers, and its investee company, HEALWELL AI, are pleased to announce the launch of the second generation WELL AI Decision Support. This enhanced version which features advanced chronic disease screening arrives just six months after the initial...
This end-to-end offering for bespoke RWE projects uses artificial intelligence (AI) to generate fit-for-purpose, analysis-ready clinical data sets months faster and reduces the burden on site staff
Deep 6 AI, the leader in AI-powered patient recruitment and real-world data (RWD), together with Magnolia Market Access, a provider of tailored RWD insights...
Lucem Health™, a leader in AI-driven early disease detection solutions, announced the introduction of Reveal for Lung Cancer. This innovative new solution aims to help healthcare organizations improve the identification and engagement of patients at a higher statistical risk for certain respiratory illnesses, including cancers of the lung or...
VantAI will leverage its proprietary large scale structural data and NVIDIA H100 GPUs on Google Cloud to enable a step-change in accuracy for all-atom protein interaction prediction
VantAI, a pioneer in generative AI-enabled drug discovery, is working with Google Cloud to power large scale distributed training and further improve internal...
Transaction is part of wide-ranging collaboration to combine Quest's oncology expertise and scale with PathAI's AI and digital pathology innovations to speed diagnosis, improve quality and reduce costs
Quest Diagnostics, a leader in diagnostic information services, and PathAI, a global provider of artificial intelligence-powered technology for pathology, announced a multi-faceted...
